Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance

Дата публикации: 07-10-2026 15:00:02

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Low-risk prostate tumors reveal molecular signs linked to more aggressive cancer	0	8.18	07-10-2026
2	New mesothelioma drug turns cancer’s own defenses against it	0	9.89	17-09-2026
3	Tracking molecular malfunctions in metastatic colorectal cancer to find new avenues for treatment	0	7.14	09-10-2026
4	Macht Millionen Mut: Forscher knacken mit Tablette Krebscode	0	8.19	09-09-2026
5	Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs	0	12.49	30-09-2026
6	Everyday DNA damage reveals a hidden weakness in some cancers	0	9.5	28-09-2026
7	Vitamin D drug may help crack pancreatic cancer’s protective shield	0	6.22	04-10-2026
8	Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working	0	7.97	30-09-2026
9	Natural protein discovery may help predict and slow aggressive cancers	0	6.86	07-07-2026
10	Scientists Untangle the Biology of an ‘Undruggable’ Cancer Gene	0	11.1	02-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.08. Источник: medicalxpress.com.